EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
Share · VGG3141W1142 · EUCRU (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % 0,20 %

Company Profile for EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT Share

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Company Data

Name EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
Company Eucrates Biomedical Acquisition Corp.
Symbol EUCRU
Primary Exchange XNAS NASDAQ
ISIN VGG3141W1142
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Mr. Parag Phoolchand Saxena MBA, MS
Market Capitalization 47 Mio
Country United States of America
Currency USD
Employees -
Address 250 West 55th Street, 10019 New York
IPO Date 2020-10-06

Ticker Symbols

Name Symbol
NASDAQ EUCRU

More Shares

Investors who EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT hold also have the following shares in their portfolio:
AUSTRALIAN BAUXITE LTD
AUSTRALIAN BAUXITE LTD Share
GLOBAL SMALL-CAP INDEX FUND - INSTITUTIONAL PLUS EUR ACC
GLOBAL SMALL-CAP INDEX FUND - INSTITUTIONAL PLUS EUR ACC Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025